Bajaj Healthcare Q4 FY26 Results Preview: Revenue, PAT & EBITDA Growth Expectations

Fri Mar 13 2026

Bajaj Healthcare Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Bajaj Healthcare was listed on the National Stock Exchange (NSE) on 25-Nov-2021. Bajaj Healthcare share has its face value of 5 per share, and its NSE symbol is BAJAJHCARE. The company operates in the Healthcare sector and primarily belongs to the Pharmaceuticals industry.

Table of Contents

Bajaj Healthcare Q4 Results 2026 Preview

Bajaj Healthcare Q4 FY26 revenue is expected to be around Strong Growth Expected, representing a 9% YoY increase compared to the same quarter last year.
Profit After Tax, or PAT, is projected to rise 18% YoY.
EBITDA to rise 5%.
Bajaj Healthcare is expected to show Strong Growth Expected in its revenue.

Click and Sign Up to Get Live Updates on Q4 Results

Bajaj Healthcare Share Performance

Over the past six months, Bajaj Healthcare share price has positive by 18% to 291.
Moreover, over the past year, the stock has positive by 51%
Despite this weak short-term performance, Bajaj Healthcare stock has delivered a financially sound 231% return over the past 5 years.
As of today, 13-03-2026, the Bajaj Healthcare share price is trading at 291 per share.

Key Factors to Watch for Bajaj Healthcare Q4 Results FY26

Revenue Growth & Segment Performance – Focus on topline growth in the Pharmaceuticals industry within the Healthcare sector.
Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.

About Bajaj Healthcare

Bajaj Healthcare operates in the healthcare segment and focuses on expanding its product portfolio, improving operational efficiency, and strengthening distribution across domestic and export markets. The company continues to focus on growth through innovation, capacity expansion, and improving margins while maintaining a strong presence in its core business segments.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Final Thoughts

Bajaj Healthcare is gear up to announce its Q4 FY26 results. Analysts expect 9% revenue growth, a 18% rise in PAT, and a 5% rise in EBITDA. Bajaj Healthcare focuses on revenue growth from order execution, margin improvement, a strong order book, and management.

Stay informed with Univest blogs to get real-time updates on Bajaj Healthcare Q4 results FY26.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.